BD8707931
(S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one , 97% , 272778-12-8
CAS NO.:272778-12-8
Empirical Formula: C39H46F2N2O5Si2
Molecular Weight: 716.96
MDL number: MFCD08460200
EINECS: 1592732-453-0
Pack Size | Price | Stock | Quantity |
100mg | RMB24.00 | In Stock |
|
250mg | RMB28.80 | In Stock |
|
1g | RMB37.60 | In Stock |
|
5g | RMB131.20 | In Stock |
|
25g | RMB444.00 | In Stock |
|
100g | RMB1463.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 190-200°C |
Boiling point: | 748.9±60.0 °C(Predicted) |
Density | 1.177 |
storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C |
solubility | Chloroform, Ethyl Acetate, Methanol |
form | Solid |
pka | 3.55±0.50(Predicted) |
color | White to Off-White |
LogP | 10.28 at 21℃ |
Description and Uses
(4R)-3-[(2S,5R)-5-(4-Fluorophenyl)-2-[(R)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone is an intermediate in the preparat ion of Ezetimibe (E975000).
Safety
Hazard statements | H413 |